Rabies virus glycoprotein and nucleoprotein antigen epitope polypeptides, and screening and identification method and application thereof

A technology of rabies virus and antigenic epitope, applied in application, antiviral agent, chemical instrument and method, etc., can solve the problems of long time, difference, and sufficient rabies virus infection and incidence of rabies virus antibodies.

Inactive Publication Date: 2013-02-13
FUDAN UNIV
View PDF2 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the immune effects of rabies virus vaccines vary greatly among the population, and it takes a long time for the titer of rabies virus antibody in the body to rise to the titer with protective effect after injection, which is not enough to produce enough vaccines during the incubation period of the virus. Antibodies against infection and pathogenesis of rabies virus

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rabies virus glycoprotein and nucleoprotein antigen epitope polypeptides, and screening and identification method and application thereof
  • Rabies virus glycoprotein and nucleoprotein antigen epitope polypeptides, and screening and identification method and application thereof
  • Rabies virus glycoprotein and nucleoprotein antigen epitope polypeptides, and screening and identification method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] 1. Acquisition of rabies virus glycoprotein and protein amino acid sequence and epitope prediction

[0027] By searching the NCBI database, the full-length amino acid sequences of the rabies virus glycoprotein and nucleoprotein were obtained, numbered gi_32440976 and gi_294999043, respectively, and the specific sequences are shown in SEQ.ID.NO.5 and SEQ.ID.NO.6. CTL epitopes and Th epitopes were predicted for the sequences of rabies virus G protein and N protein obtained in the NCBI database. Mouse MHC class I molecules including H-2k d , H-2D d and H-2L d Three subclasses, MHC class II molecules include I-A d and I-E d Two subclasses. Therefore, in order to obtain CTL and Th epitopes, it is necessary to analyze and predict these subclasses respectively. For MHC class I molecules, SYFPEITHI and BIMAS software were used for prediction, and six sequences with higher common scores were selected, as shown in Table 1. For MHC-II molecules, RANKPEP software was used ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of biology, and particularly relates to screening and identification of antigen epitope polypeptides. The invention discloses screening, identification and application of a series of rabies virus glycoprotein and nucleoprotein antigen epitope polypeptides. The rabies virus glycoprotein and nucleoprotein are predicted by biological information means to obtain the candidate epitope polypeptides; and a lymphopoiesis experiment, ELISPOT experiment and a stream-type cell method are utilized to carry out in-vitro experimental verification on the subsequent epitope polypeptides to obtain the four rabies virus protein antigen epitope polypeptides. The invention is characterized in that the antigen epitope polypeptides respectively comprise a Th epitope and a CTL epitope, can stimulate the lymphopoiesis of the vaccine-immunized mouse in vitro and induce the cells to secrete related cell factors, and have the functions of killing virus-infected cells and stimulating the generation of the antibody. The invention can be used for developing rabies virus epitope vaccines and detecting the vaccine effect, and has important value for developing and producing immunologic function detection kits for rabies virus vaccines.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a rabies virus glycoprotein and nucleoprotein epitope, a screening and identification method and application thereof. Background technique [0002] Rabies is a relatively serious acute infectious disease that currently threatens human health. Once a human patient is bitten by a sick animal and becomes ill, the mortality rate is as high as 95%. The rabies virus belongs to the rhabdoviridae family (rhabdoviridae), lyssa virus (lyssa virus), and is bullet-shaped. Rabies virus can invade the human body through damaged skin or mucous membranes, and enter the central nervous system (CNS) of humans and all warm-blooded animals through nerve endings to cause rabies. The rabies virus genome nucleic acid is a single-stranded negative-strand RNA without segments, consisting of 11928 or 11932 nucleotides, with a relative molecular weight of about 4.6×10 6 , N, P, M, G, L genes are ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/06C07K7/08C12N15/47C12N15/63C07K19/00C12Q1/02A61K39/205A61P31/14G01N33/68
Inventor 朱乃硕胡晓波
Owner FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products